The expression of the neuropeptide Y (NPY) gene caries considerably in huma
n pheochromocytomas, but the mechanisms for this variation have not been cl
arified. To investigate the regulation pattern of the NPY gene in human phe
ochromocytomas, we screened 16 pheochromocytomas and 9 normal adrenal tissu
es with Northern blots. The expression level of NPY mRNA in normal adrenal
medulla was low and relatively constant, while the pheochromocytomas showed
a very wide variation in NPY mRNA levels in both malignant and benign tumo
rs. This indicates that NPY gene expression is not correlated with malignan
cy in pheochromocytomas. In primary cultures of human pheochromocytoma cell
s, nerve growth factor treatment (causing neuronal differentiation) increas
ed NPY mRNA accumulation 2- to 5-fold (P< 0.05). NPY mRNA levels were also
induced by protein kinase modulators (Bu)(2)cAMP and staurosporine in the c
ultures (P < 0.05). In contrast, treatment with dexamethasone and IGF-II (c
ausing or linked with chromaffin differentiation) reduced NPY mRNA accumula
tion (P < 0.05). These data show that the regulation pattern of NPY mRNA ex
pression in cultured human pheochromocytoma cells is different from that pr
eviously described in rat pheochromocytoma PC12 cells. Regulation of NPY mR
NA expression in primary cultures by these differentiating factors suggests
that the expression of NPY mRNA in pheochromocytoma tissues may be associa
ted with the neuronal differentiation of the tumor cells affected by multip
le factors.